Skip to main content
Clinical Trials/ACTRN12624000096550
ACTRN12624000096550
Recruiting
未知

Stepped Care in the Treatment of Disordered Eating: A Randomised Controlled Pilot and Feasibility Study Comparing CBT-E to Guided-Self Help.

a Trobe University0 sites100 target enrollmentFebruary 2, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
eating disorder
Sponsor
a Trobe University
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 2, 2024
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
a Trobe University

Eligibility Criteria

Inclusion Criteria

  • \* Age \- 18 years or older
  • Disordered eating \- Diagnosis of bulimia nervosa (BN), binge\-eating disorder (BED), other\-specified feeding or eating disorder (OSFED), unspecified feeding or eating disorder (UFED), based on EDE 17\.0D assessment
  • Medical monitoring\- Participant has a GP who is aware of participant’s disordered eating. Both participant and GP are willing to conduct medical monitoring during the trial. At a minimum, medical monitoring will include a medical assessment prior to study commencement, and at any point at which (i) the treating clinician deems it appropriate (e.g., where there are indicators of medical risk or instability) or (ii) the GP deems it necessary.Consent is provided by the participant for treating clinicians to share clinical information with their nominated GP and any other members of their treating team (e.g., dietician, psychiatrist) and for the GP to share clinical information with the treating clinician.
  • Suicide risk \- No thoughts of suicide or self\-harm, OR Irregular or fleeting thoughts of suicide or self\-harm without intent or plan. Self\-harm does not include binge eating, purging, laxative use or excessive exercise occurring as a symptom of disordered eating.
  • Medically StableBlood pressure, heart rate, Biochemistry including electrolytes indicate medical stability as assessed by the GP. No current rapid weight loss
  • Purging behaviour Low frequency. Fewer than 3 instances per day
  • Psychological riskNo comorbid severe mental health disorder (e.g., depression, anxiety symptoms in the severe to extremely severe range) OR Symptoms likely to interfere with engagement in treatment (e.g., active psychosis)
  • Recent hospital admissionNo eating disorder or other psychiatric (including self\-harm) related hospital admission in previous 12 months.
  • Drug and alcoholNo drug and alcohol issues
  • BMIBMI \>17\.5kg/m2

Exclusion Criteria

  • \* Age \- under 18 years
  • \* Disordered eating \- Diagnosis of Anorexia nervosa (AN). No diagnosis of an eating disorder
  • \* Medical monitoring \- Participant does not want GP involved or unable to establish regular GP monitoring.
  • \* Suicide risk \- Regular thoughts or intent of suicide or self\-harm, OR Current plan OR Previous attempts OR Serious and intentional self\-harm
  • \* Medically stable \- Medically unstable i.e. Blood pressure, heart rate, electrolytes, cardiac function indicate medical instability or risk as assessed by the GP, OR Rapid weight loss (current), severe emaciation, OR Severe unstable medical comorbidity (e.g., unstable diabetes)
  • \* Purging behaviour \- Purging after every food/fluid intake or \= than three instances per day. Haematemesis
  • \* Psychological risk \- Acute comorbid mental health disorder. Depression, Anxiety or Stress in Severe category (DASS21\). Symptoms of psychosis
  • \* Recent hospital admission \- Long eating disorder or psychiatric (including self\-harm) related admission history with minimal recovery OR Eating disorder or psychiatric (including self\-harm) related hospital admission in previous 12 months.
  • \* Drug and alcohol \- Current active or untreated drug and alcohol use
  • \* BMI \- BMI less than 17\.5kg/m2

Outcomes

Primary Outcomes

Not specified

Similar Trials